A Phase 3, Randomized, Double-blind, Placebo-controlled Study of Lusutrombopag for Thrombocytopenia in Patients with Chronic Liver Disease Undergoing Elective Invasive Procedures in Japan (L-PLUS 1)

被引：0
|
作者：
Izumi, Namiki [1 ]
Osaki, Yukio [2 ]
Yamamoto, Kazuhide [3 ]
Kurokawa, Mineo [4 ]
Tanaka, Katsuaki [5 ]
Kano, Takeshi [6 ]
Fukuhara, Takahiro [6 ]
Ochiai, Toshimitsu [6 ]
Imawari, Michio [7 ]
机构：
[1] Musashino Red Cross Hosp, Tokyo, Japan
[2] Osaka Red Cross Hosp, Osaka, Japan
[3] Okayama Univ, Okayama 7008530, Japan
[4] Univ Tokyo, Tokyo, Japan
[5] Yokohama City Univ, Med Ctr, Yokohama, Kanagawa 232, Japan
[6] Shionogi & Co Ltd, Osaka, Japan
[7] Shin Yurigaoka Gen Hosp, Kawasaki, Kanagawa, Japan
来源：
HEPATOLOGY | 2015年 / 62卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
LB-30
引用
收藏
页码：1397A / 1398A
页数：2
相关论文
共 50 条
  • [31] Alicaforsen Enema in Chronic Pouchitis: Results of a Phase 3 Randomized, Double-blind, Placebo-controlled Trial
    Feagan, Brian
    Lindsay, James
    Rogler, Gerhard
    Moran, Gordon
    Varawalla, Nermeen
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2021, 116 : S364 - S364
  • [32] An international, randomized, double-blind, placebo-controlled phase 3 trial of intramuscular alefacept in patients with chronic plaque psoriasis
    Lebwohl, M
    Christophers, E
    Langley, R
    Ortonne, JP
    Roberts, J
    Griffiths, CEM
    [J]. ARCHIVES OF DERMATOLOGY, 2003, 139 (06) : 719 - 727
  • [33] A Randomized, Double-blind, Placebo-Controlled Study of Latrepirdine in Patients With Mild to Moderate Huntington Disease
    Kieburtz, Karl
    Landwehrmeyer, Georg B.
    Cudkowicz, Merit
    Dorsey, E. Ray
    Feigin, Andrew
    Hunt, Victoria
    Kayson, Elise
    McDermott, Michael
    Noonberg, Sarah
    Seitz, Wendy
    Soliveri, Paola
    Walker, Francis
    Burgunder, Jean-Marc
    Romero, Irene
    Magara, Anouk
    Stebler, Yanik
    Rickards, Hugh
    Wright, Jan
    De Souza, Jenny
    Barker, Roger A.
    Mason, Sarah
    Di Pietro, Anna
    Goodman, Anna
    O'Keeffe, Deidre
    Langlois, Melanie
    Ferland, Germain
    Verret, Louis
    Chouinard, Sylvain
    Paris, Suzanne
    LePage, Christiane
    Nemeth, Andrea H.
    Merritt, Claire
    Cox, Caroline
    Astbury, Therese
    Murphy, Sarah
    Ahmed, Anwar
    St Marie, Patricia
    Berila, Rose Anne
    Kubu, Cynthia
    Segro, Vicki
    Kumar, Rajeev
    Erickson, Diane
    Schneiders, Jay
    Frucht, Steven
    Wasserman, Paula
    Moskowitz, Carol
    Scott, Burton
    Perry-Trice, Peggy
    Wyne, Sarah
    Soliveri, Paola
    [J]. JAMA NEUROLOGY, 2013, 70 (01) : 25 - 33
  • [34] AMAGINE-1: a phase 3, randomized, double-blind, placebo-controlled study of brodalumab in subjects with psoriasis
    Papp, K.
    Reich, K.
    Leonardi, C.
    Paul, C.
    Blauvelt, A.
    Baran, W.
    Bolduc, C.
    Toth, D.
    Langley, R. G.
    Cather, J.
    Gottlieb, A. B.
    Thaci, D.
    Milmont, C. E.
    Li, J.
    Klekotka, P.
    Kricorian, G.
    Nirula, A.
    [J]. BRITISH JOURNAL OF DERMATOLOGY, 2014, 171 (06) : E119 - E120
  • [35] THE APPROACH STUDY: A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PHASE 3 STUDY OF VOLANESORSEN ADMINISTERED SUBCUTANEOUSLY TO PATIENTS WITH FCS
    Gaudet, Daniel
    Digenio, Andres
    Alexander, Veronica J.
    Arca, Marcello
    Jones, Alan F.
    Stroes, Erik
    Bergeron, Jean
    Civeira, Fernando
    Hemphill, Linda C.
    Blom, Dirk J.
    Flaim, Joann
    Hughes, Steven
    Geary, Richard
    Tsimikas, Sotirios
    Bruckert, Eric
    [J]. ATHEROSCLEROSIS SUPPLEMENTS, 2018, 32 : 14 - +
  • [36] Vericiguat: A Randomized, Phase Ib, Placebo-Controlled, Double-Blind, QTc Interval Study in Patients with Chronic Coronary Syndromes
    Michael Böttcher
    Hans-Dirk Düngen
    Vasile Corcea
    Frank Donath
    Rainard Fuhr
    Pim Gal
    Gerd Mikus
    Dietmar Trenk
    Martin Coenen
    Philippe Vieira Pires
    Claudia Maschke
    Antonios Othon Aliprantis
    Nina Besche
    Corina Becker
    [J]. American Journal of Cardiovascular Drugs, 2023, 23 : 145 - 155
  • [37] Randomized, double-blind, placebo-controlled phase II trial of nanocurcumin in prostate cancer patients undergoing radiotherapy
    Saadipoor, Afshin
    Razzaghdoust, Abolfazl
    Simforoosh, Nasser
    Mahdavi, Arash
    Bakhshandeh, Mohsen
    Moghadam, Maryam
    Abdollahi, Hamid
    Mofid, Bahram
    [J]. PHYTOTHERAPY RESEARCH, 2019, 33 (02) : 370 - 378
  • [38] Vericiguat: A Randomized, Phase Ib, Placebo-Controlled, Double-Blind, QTc Interval Study in Patients with Chronic Coronary Syndromes
    Boettcher, Michael
    Duengen, Hans-Dirk
    Corcea, Vasile
    Donath, Frank
    Fuhr, Rainard
    Gal, Pim
    Mikus, Gerd
    Trenk, Dietmar
    Coenen, Martin
    Pires, Philippe Vieira
    Maschke, Claudia
    Aliprantis, Antonios Othon
    Besche, Nina
    Becker, Corina
    [J]. AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS, 2023, 23 (02) : 145 - 155
  • [39] Ginger Supplementation in Nonalcoholic Fatty Liver Disease: A Randomized, Double-Blind, Placebo-Controlled Pilot Study
    Rahimlou, Mehran
    Yari, Zahra
    Hekmatdoost, Azita
    Alavian, Seyed Moayed
    Keshavarz, Seyed Ali
    [J]. HEPATITIS MONTHLY, 2016, 16 (01)
  • [40] Randomized, Double-blind, Placebo-controlled Study of a Multispecies Probiotic Mixture in Nonalcoholic Fatty Liver Disease
    Anh, Sang Bong
    Jun, Dae Won
    Kang, Bo-Kyeong
    Lim, Jong Hyun
    Lim, Sanghyun
    Chung, Myung-Jun
    [J]. SCIENTIFIC REPORTS, 2019, 9 (1)
12345